litlas
Log inCreate account

James Stevenson

Active 1981–2026

76
Papers
17,973
Citations
49
h-index
68
i10-index

Citations

Citations per year for James Stevenson1983: 1 citations1986: 1 citations1988: 2 citations1989: 1 citations1990: 3 citations1991: 9 citations1992: 20 citations1993: 16 citations1994: 25 citations1995: 24 citations1996: 21 citations1997: 26 citations1998: 27 citations1999: 20 citations2000: 28 citations2001: 29 citations2002: 33 citations2003: 50 citations2004: 51 citations2005: 70 citations2006: 69 citations2007: 83 citations2008: 52 citations2009: 58 citations2010: 69 citations2011: 55 citations2012: 60 citations2013: 35 citations2014: 43 citations2015: 45 citations2016: 52 citations2017: 124 citations2018: 177 citations2019: 618 citations2020: 720 citations2021: 697 citations2022: 538 citations2023: 388 citations2024: 791 citations2025: 362 citations2026: 25 citations1984–1985: no citations, so these years are not shown1987: no citations, so this year is not shown

Citation sources

Countries

World map of the countries and regions citing this authorUnited States: 1,956 citing papers, 24% of this breakdownChina: 1,491 citing papers, 18.3% of this breakdownUnited Kingdom: 420 citing papers, 5.2% of this breakdownItaly: 384 citing papers, 4.7% of this breakdownGermany: 294 citing papers, 3.6% of this breakdownFrance: 277 citing papers, 3.4% of this breakdownCanada: 271 citing papers, 3.3% of this breakdownJapan: 264 citing papers, 3.3% of this breakdownSpain: 228 citing papers, 2.8% of this breakdownAustralia: 209 citing papers, 2.6% of this breakdownIndia: 188 citing papers, 2.3% of this breakdownNetherlands: 183 citing papers, 2.3% of this breakdown
0%24%Other 24.2%

Institutions

Fields

  • Medicine66.9%
  • Biochemistry, Genetics and Molecular Biology16.4%
  • Computer Science5.2%
  • Neuroscience2.3%
  • Immunology and Microbiology1.8%
  • Psychology1.7%
  • Other5.7%

Topics

  • Cancer Immunotherapy and Biomarkers8.9%
  • Lung Cancer Treatments and Mutations8.2%
  • Lung Cancer Diagnosis and Treatment6.1%
  • Lung Cancer Research Studies5.3%
  • Cancer Genomics and Diagnostics2.3%
  • Radiomics and Machine Learning in Medical Imaging2.1%
  • Other67.1%

Coauthors

All papers

Open in search
  1. Non–Small Cell Lung Cancer, Version 3.2022, NCCN Clinical Practice Guidelines in Oncology

    Authors: David S. Ettinger, Douglas E. Wood, Dara L. Aisner, Wallace Akerley, Jessica R. Bauman, Ankit Bharat, Débora S. Bruno, Joe Y. Chang, Lucian R. Chirieac, Thomas A. D’Amico, Malcolm M. DeCamp, Thomas J. Dilling, Jonathan E. Dowell, Scott Gettinger, Travis E. Grotz, Matthew A. Gubens, Aparna Hegde, Rudy P. Lackner, Michael Lanuti, Jules Lin, Billy W. Loo, Christine M. Lovly, Fabien Maldonado, Erminia Massarelli, Daniel Morgensztern, Thomas Ng, Gregory A. Otterson, Jose M. Pacheco, Sandip Pravin Patel, Gregory J. Riely, Jonathan W. Riess, Steven E. Schild, Theresa A. Shapiro, Aditi P. Singh, James Stevenson, Alda L. Tam, Tawee Tanvetyanon, Jane Yanagawa, Stephen C. Yang, Edwin Yau, Kristina M. Gregory, Miranda Hughes - Journal of the National Comprehensive Cancer Network 2022 cited by 1,419

  2. OPLS3e: Extending Force Field Coverage for Drug-Like Small Molecules

    Authors: Katarina Roos, Chuanjie Wu, Wolfgang Damm, Mark Reboul, James Stevenson, Chao Lü, Markus K. Dahlgren, Sayan Mondal, Wei Chen, Lingle Wang, Robert Abel, Richard A. Friesner, Edward Harder - Journal of Chemical Theory and Computation 2019 cited by 1,273

  3. NCCN Guidelines® Insights: Non–Small Cell Lung Cancer, Version 2.2023

    Authors: David S. Ettinger, Douglas E. Wood, Dara L. Aisner, Wallace Akerley, Jessica R. Bauman, Ankit Bharat, Débora S. Bruno, Joe Y. Chang, Lucian R. Chirieac, Malcolm M. DeCamp, Thomas J. Dilling, Jonathan E. Dowell, Gregory A. Durm, Scott Gettinger, Travis E. Grotz, Matthew A. Gubens, Aparna Hegde, Rudy P. Lackner, Michael Lanuti, Jules Lin, Billy W. Loo, Christine M. Lovly, Fabien Maldonado, Erminia Massarelli, Daniel Morgensztern, Thomas Ng, Gregory A. Otterson, Sandip Pravin Patel, Tejas Patil, Patricio M. Polanco, Gregory J. Riely, Jonathan W. Riess, Steven E. Schild, Theresa A. Shapiro, Aditi P. Singh, James Stevenson, Alda L. Tam, Tawee Tanvetyanon, Jane Yanagawa, Stephen C. Yang, Edwin Yau, Kristina M. Gregory, Miranda Hughes - Journal of the National Comprehensive Cancer Network 2023 cited by 483

  4. Non–Small Cell Lung Cancer, Version 4.2024

    Authors: Gregory J. Riely, Douglas E. Wood, David S. Ettinger, Dara L. Aisner, Wallace Akerley, Jessica R. Bauman, Ankit Bharat, Débora S. Bruno, Joe Y. Chang, Lucian R. Chirieac, Malcolm M. DeCamp, Aakash Desai, Thomas J. Dilling, Jonathan E. Dowell, Gregory A. Durm, Scott Gettinger, Travis E. Grotz, Matthew A. Gubens, Aditya Juloori, Rudy P. Lackner, Michael Lanuti, Jules Lin, Billy W. Loo, Christine M. Lovly, Fabien Maldonado, Erminia Massarelli, Daniel Morgensztern, Trey C. Mullikin, Thomas Ng, Dawn Owen, Dwight H. Owen, Sandip Pravin Patel, Tejas Patil, Patricio M. Polanco, Jonathan W. Riess, Theresa A. Shapiro, Aditi P. Singh, James Stevenson, Alda L. Tam, Tawee Tanvetyanon, Jane Yanagawa, Stephen C. Yang, Edwin Yau, Kristina M. Gregory, Lisa Hang - Journal of the National Comprehensive Cancer Network 2024 cited by 756

  5. DGIdb 5.0: rebuilding the drug–gene interaction database for precision medicine and drug discovery platforms

    Authors: Matthew Cannon, James Stevenson, Kathryn Stahl, Rohit Basu, Adam Coffman, Susanna Kiwala, Joshua F. McMichael, Kori Kuzma, Dorian Morrissey, Kelsy C. Cotto, Elaine R. Mardis, Obi L. Griffith, Malachi Griffith, Alex H. Wagner - Nucleic Acids Research 2023 cited by 445

  6. NCCN Guidelines Insights: Non–Small Cell Lung Cancer, Version 2.2021

    Authors: David S. Ettinger, Douglas E. Wood, Dara L. Aisner, Wallace Akerley, Jessica R. Bauman, Ankit Bharat, Débora S. Bruno, Joe Y. Chang, Lucian R. Chirieac, Thomas A. D’Amico, Thomas J. Dilling, Jonathan E. Dowell, Scott Gettinger, Matthew A. Gubens, Aparna Hegde, Mark Hennon, Rudy P. Lackner, Michael Lanuti, Ticiana Leal, Jules Lin, Billy W. Loo, Christine M. Lovly, Renato Martins, Erminia Massarelli, Daniel Morgensztern, Thomas Ng, Gregory A. Otterson, Sandip Pravin Patel, Gregory J. Riely, Steven E. Schild, Theresa A. Shapiro, Aditi P. Singh, James Stevenson, Alda L. Tam, Jane Yanagawa, Stephen C. Yang, Kristina M. Gregory, Miranda Hughes - Journal of the National Comprehensive Cancer Network 2021 cited by 1,006

  7. Carboplatin and pemetrexed with or without pembrolizumab for advanced, non-squamous non-small-cell lung cancer: a randomised, phase 2 cohort of the open-label KEYNOTE-021 study

    Authors: Corey J. Langer, Shirish M. Gadgeel, Hossein Borghaei, Vassiliki A. Papadimitrakopoulou, Amita Patnaik, Steven Powell, Ryan D. Gentzler, Renato Martins, James Stevenson, Shadia I. Jalal, Amit Panwalkar, James Chih‐Hsin Yang, Matthew A. Gubens, Lecia V. Sequist, Mark M. Awad, Joseph Fiore, Yang Ge, Harry Raftopoulos, Leena Gandhi - The Lancet Oncology 2016 cited by 1,392

  8. Non–Small Cell Lung Cancer, Version 5.2017, NCCN Clinical Practice Guidelines in Oncology

    Authors: David S. Ettinger, Douglas E. Wood, Dara L. Aisner, Wallace Akerley, Jessica R. Bauman, Lucian R. Chirieac, Thomas A. D’Amico, Malcolm M. DeCamp, Thomas J. Dilling, M.C. Dobelbower, Robert C. Doebele, Ramaswamy Govindan, Matthew A. Gubens, Mark Hennon, Leora Horn, Ritsuko Komaki, Rudy P. Lackner, Michael Lanuti, Ticiana Leal, Leah J. Leisch, Rogerio Lilenbaum, Jules Lin, Billy W. Loo, Renato Martins, Gregory A. Otterson, Karen L. Reckamp, Gregory J. Riely, Steven E. Schild, Theresa A. Shapiro, James Stevenson, Steven Swanson, Kurt W. Tauer, Stephen C. Yang, Kristina M. Gregory, Miranda Hughes - Journal of the National Comprehensive Cancer Network 2017 cited by 1,325

  9. NCCN Guidelines Insights: Non–Small Cell Lung Cancer, Version 1.2020

    Authors: David S. Ettinger, Douglas E. Wood, Charu Aggarwal, Dara L. Aisner, Wallace Akerley, Jessica R. Bauman, Ankit Bharat, Débora S. Bruno, Joe Y. Chang, Lucian R. Chirieac, Thomas A. D’Amico, Thomas J. Dilling, M.C. Dobelbower, Scott Gettinger, Ramaswamy Govindan, Matthew A. Gubens, Mark Hennon, Leora Horn, Rudy P. Lackner, Michael Lanuti, Ticiana Leal, Jules Lin, Billy W. Loo, Renato Martins, Gregory A. Otterson, Sandip Pravin Patel, Karen L. Reckamp, Gregory J. Riely, Steven E. Schild, Theresa A. Shapiro, James Stevenson, Scott J. Swanson, Kurt W. Tauer, Stephen C. Yang, Kristina M. Gregory, OCN, Miranda Hughes - Journal of the National Comprehensive Cancer Network 2019 cited by 1,005

  10. Incidence of Pneumonitis With Use of Programmed Death 1 and Programmed Death-Ligand 1 Inhibitors in Non-Small Cell Lung Cancer

    Authors: Monica Khunger, Sagar Rakshit, Vinay Pasupuleti, Adrían V. Hernández, Peter J. Mazzone, James Stevenson, Nathan A. Pennell, Vamsidhar Velcheti - CHEST Journal 2017 cited by 499

  11. NCCN Guidelines Insights: Non–Small Cell Lung Cancer, Version 4.2016

    Authors: David S. Ettinger, Douglas E. Wood, Wallace Akerley, Lyudmila Bazhenova, Hossein Borghaei, David Ross Camidge, Richard T. Cheney, Lucian R. Chirieac, Thomas A. D’Amico, Thomas J. Dilling, M.C. Dobelbower, Ramaswamy Govindan, Mark Hennon, Leora Horn, Thierry Jahan, Ritsuko Komaki, Rudy P. Lackner, Michael Lanuti, Rogério Lilenbaum, Jules Lin, Billy W. Loo, Renato Martins, Gregory A. Otterson, Jyoti D. Patel, Katherine M.W. Pisters, Karen L. Reckamp, Gregory J. Riely, Steven E. Schild, Theresa A. Shapiro, Neelesh Sharma, James Stevenson, Steven Swanson, Kurt W. Tauer, Stephen C. Yang, Kristina M. Gregory, Miranda Hughes - Journal of the National Comprehensive Cancer Network 2016 cited by 738

  12. Long-Term Overall Survival From KEYNOTE-021 Cohort G: Pemetrexed and Carboplatin With or Without Pembrolizumab as First-Line Therapy for Advanced Nonsquamous NSCLC

    Authors: Mark M. Awad, Shirish M. Gadgeel, Hossein Borghaei, Amita Patnaik, James Chih‐Hsin Yang, Steven Powell, Ryan D. Gentzler, Renato Martins, James Stevenson, Mehmet Altan, Shadia I. Jalal, Amit Panwalkar, Matthew A. Gubens, Lecia V. Sequist, Sanatan Saraf, Bin Zhao, Bilal Piperdi, Corey J. Langer - Journal of Thoracic Oncology 2020 cited by 183

  13. Phase II Study of Maintenance Pembrolizumab in Patients with Extensive-Stage Small Cell Lung Cancer (SCLC)

    Authors: Shirish M. Gadgeel, Nathan A. Pennell, Mary J. Fidler, Balázs Halmos, Philip Bonomi, James Stevenson, Bryan J. Schneider, Ammar Sukari, Jaclyn Ventimiglia, Wei Chen, Cathy Galasso, Antoinette J. Wozniak, Julie L. Boerner, Gregory P. Kalemkerian - Journal of Thoracic Oncology 2018 cited by 224

  14. 24-Month Overall Survival from KEYNOTE-021 Cohort G: Pemetrexed and Carboplatin with or without Pembrolizumab as First-Line Therapy for Advanced Nonsquamous Non–Small Cell Lung Cancer

    Authors: Hossein Borghaei, Corey J. Langer, Shirish M. Gadgeel, Vassiliki A. Papadimitrakopoulou, Amita Patnaik, Steven Powell, Ryan D. Gentzler, Renato Martins, James Stevenson, Shadia I. Jalal, Amit Panwalkar, James Chih‐Hsin Yang, Matthew A. Gubens, Lecia V. Sequist, Mark M. Awad, Joseph Fiore, Sanatan Saraf, Steven M. Keller, Leena Gandhi - Journal of Thoracic Oncology 2018 cited by 197

  15. AI-readiness Criteria for Biomedical Data

    Authors: Tim W. Clark, J. Harry Caufield, Jillian A. Parker, Mohammad Sadnan Al Manir, Edilberto Amorim, James A. Eddy, Nayoon Gim, Brian Gow, Wesley Goar, Jan N. Hansen, Nomi Harris, Henning Hermjakob, Marcin Joachimiak, Gianna Jordan, In-Hee Lee, Shannon K. McWeeney, Camille Nebeker, Milen Nikolov, Sarah J. Ratcliffe, Jamie Shaffer, Nathan C. Sheffield, Gloria Sheynkman, James Stevenson, Jake Y. Chen, Chris Mungall, Alex H. Wagner, Sek Won Kong, Satrajit Ghosh, Bhavesh Patel, Andrew E. Williams, Mónica Muñoz-Torres, Mónica Muñoz-Torres - 2024 cited by 23

  16. Pembrolizumab in combination with ipilimumab as second-line or later therapy for advanced non–small-cell lung cancer: KEYNOTE-021 cohorts D and H

    Authors: Matthew A. Gubens, Lecia V. Sequist, James Stevenson, Steven Powell, Liza C. Villaruz, Shirish M. Gadgeel, Corey J. Langer, Amita Patnaik, Hossein Borghaei, Shadia I. Jalal, Joseph Fiore, Sanatan Saraf, Harry Raftopoulos, Leena Gandhi - Lung Cancer 2018 cited by 80

  17. Programmed Cell Death 1 (PD-1) Ligand (PD-L1) Expression in Solid Tumors As a Predictive Biomarker of Benefit From PD-1/PD-L1 Axis Inhibitors: A Systematic Review and Meta-Analysis

    Authors: Monica Khunger, Adrían V. Hernández, Vinay Pasupuleti, Sagar Rakshit, Nathan A. Pennell, James Stevenson, Sanjay Mukhopadhyay, Kurt A. Schalper, Vamsidhar Velcheti - JCO Precision Oncology 2017 cited by 150

  18. NCCN Guidelines Insights: Non–Small Cell Lung Cancer, Version 5.2018

    Authors: David S. Ettinger, Dara L. Aisner, Douglas E. Wood, Wallace Akerley, Jessica R. Bauman, Joe Y. Chang, Lucian R. Chirieac, Thomas A. D’Amico, Thomas J. Dilling, M.C. Dobelbower, Ramaswamy Govindan, Matthew A. Gubens, Mark Hennon, Leora Horn, Rudy P. Lackner, Michael Lanuti, Ticiana Leal, Rogério Lilenbaum, Jules Lin, Billy W. Loo, Renato Martins, Gregory A. Otterson, Sandip Pravin Patel, Karen L. Reckamp, Gregory J. Riely, Steven E. Schild, Theresa A. Shapiro, James Stevenson, Steven Swanson, Kurt W. Tauer, Stephen C. Yang, Kristina M. Gregory, Miranda Hughes - Journal of the National Comprehensive Cancer Network 2018 cited by 471

  19. Pilot and Feasibility Trial Evaluating Immuno-Gene Therapy of Malignant Mesothelioma Using Intrapleural Delivery of Adenovirus-IFNα Combined with Chemotherapy

    Authors: Daniel H. Sterman, Evan Alley, James Stevenson, Joseph S. Friedberg, Susan Metzger, Adri Recio, Edmund K. Moon, Andrew R. Haas, Anil Vachani, Sharyn I. Katz, Jing Sun, Daniel F. Heitjan, Wei‐Ting Hwang, Leslie A. Litzky, Jennifer H. Yearley, Kay See Tan, Emmanouil Papasavvas, Paul Kennedy, Luis J. Montaner, Keith A. Cengel, Charles B. Simone, Melissa Culligan, Corey J. Langer, Steven Μ. Albelda - Clinical Cancer Research 2016 cited by 98

  20. Phase II study of stereotactic radiosurgery for the treatment of patients with oligoprogression on erlotinib

    Authors: Jared Weiss, Brian D. Kavanagh, Allison M. Deal, L. Villaruz, James Stevenson, D. Ross Camidge, Hossein Borghaei, Jack West, Padmini Kirpalani, David E. Morris, Carrie B. Lee, Chad V. Pecot, Timothy M. Zagar, Thomas E. Stinchcombe, Nathan A. Pennell - Cancer Treatment and Research Communications 2019 cited by 48

  21. Mechanisms of Hypertension Associated With BAY 43-9006

    Authors: Maria Luisa Veronese, Ari Mosenkis, Keith T. Flaherty, Maryann Gallagher, James Stevenson, Raymond R. Townsend, Peter J. O’Dwyer - Journal of Clinical Oncology 2006 cited by 320

  22. Photodynamic therapy for the treatment of non-small cell lung cancer.

    Authors: Charles B. Simone, Joseph S. Friedberg, Eli Glatstein, James Stevenson, Daniel H. Sterman, Stephen M. Hahn, Keith A. Cengel - 2012 cited by 105

  23. Immunological effects of the TGFβ-blocking antibody GC1008 in malignant pleural mesothelioma patients

    Authors: James Stevenson, Hedy L. Kindler, Emmanouil Papasavvas, Jing Sun, Mona Jacobs-Small, Jennifer J. Hull, Daniel Schwed, Anjana Ranganathan, Kheng Newick, Daniel F. Heitjan, Corey J. Langer, John M. McPherson, Luis J. Montaner, Steven Μ. Albelda - OncoImmunology 2013 cited by 81

  24. Clinical Outcomes of the HIV Protease Inhibitor Nelfinavir With Concurrent Chemoradiotherapy for Unresectable Stage IIIA/IIIB Non–Small Cell Lung Cancer

    Authors: Ramesh Rengan, Rosemarie Mick, Daniel A. Pryma, Lilie L. Lin, John P. Christodouleas, John P. Plastaras, Charles B. Simone, Anjali Gupta, Tracey L. Evans, James Stevenson, Corey J. Langer, John C. Kucharczuk, Joseph S. Friedberg, Sarah Lam, Dana Patsch, Stephen M. Hahn, Amit Maity - JAMA Oncology 2019 cited by 36